Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open letter to customers: To Catalent’s Valued Customers, I want to correct a few key inaccuracie... Read more
Telix Pharmaceuticals provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024). Revenue update, full year guidance reaffirmed Unaudited total revenue of approximately US$135 million (AU$20... Read more
"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that integrating ESG principles into our operations improves our business resilience and positions u... Read more
The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microRNA, a vital molecular mechanism that plays a key role in regulating gene activity. This breakth... Read more
Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1.2m from Barclays Corporate Bank PLC. Symbiosis Pharmaceutical Services Ltd (Symbiosi... Read more
Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentr... Read more
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open letter to customers: To Catalent’s Valued Customers, I want to correct a few key inaccuracie... Read more
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced it has signed a definitive agreement to acquire Catalent’s state... Read more
© 2024 Biopharma Boardroom. All Rights Reserved.